{"generic":"Ciclopirox","drugs":["Ciclodan","Ciclopirox","CNL8","Loprox","Loprox TS","Penlac"],"mono":{"0":{"id":"jtuus0","title":"Generic Names","mono":"Ciclopirox"},"1":{"id":"jtuus1","title":"Dosing and Indications","sub":{"0":{"id":"jtuus1b4","title":"Adult Dosing","mono":"<ul><li>TOPICAL, apply gel twice daily to affected areas for 4 weeks<\/li><li><b>Onychomycosis due to dermatophyte (Mild to Moderate), Fingernails and toenails:<\/b> TOPICAL, apply lacquer once daily to affected nails with applicator brush; remove with alchohol every 7 days<\/li><li><b>Seborrheic dermatitis of scalp:<\/b> (0.77% gel) apply gel TOPICALLY twice daily to affected areas for 4 weeks<\/li><li><b>Seborrheic dermatitis of scalp:<\/b> (1% shampoo) apply 5 mL TOPICALLY to the wet scalp (up to 10 mL for long hair), lather, leave on for 3 minutes, then rinse; repeat twice per week for 4 weeks with at least 3 days between applications<\/li><li><b>Tinea, Superficial:<\/b> TOPICAL, gently massage gel into affected area twice daily for 4 weeks<\/li><\/ul>"},"1":{"id":"jtuus1b5","title":"Pediatric Dosing","mono":"<ul><li>Use of gel\/shampoo not FDA approved in children less than 16 years old<\/li><li><b>Seborrheic dermatitis of scalp:<\/b> (0.77% gel) 16 y and older, apply gel TOPICALLY twice daily to affected areas for 4 weeks<\/li><li><b>Seborrheic dermatitis of scalp:<\/b> (1% shampoo) 16 y and older, apply 5 mL TOPICALLY to the wet scalp (up to 10 mL for long hair), lather, leave on for 3 minutes, then rinse; repeat twice per week for 4 weeks with at least 3 days between applications<\/li><li><b>Tinea, Superficial:<\/b> (16 y and older) TOPICAL, gently massage gel into affected area twice daily for 4 weeks<\/li><\/ul>"},"3":{"id":"jtuus1b7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Onychomycosis due to dermatophyte (Mild to Moderate), Fingernails and toenails<\/li><li>Seborrheic dermatitis of scalp<\/li><li>Tinea, Superficial<\/li><\/ul>"}}},"3":{"id":"jtuus3","title":"Contraindications\/Warnings","sub":[{"id":"jtuus3b9","title":"Contraindications","mono":"specific contraindications have not been determined <br\/>"},{"id":"jtuus3b10","title":"Precautions","mono":"<ul><li>eye contact should be avoided; rinse eye(s) thoroughly with water if contact occurs<\/li><li>sensitivity or irritation has been reported; discontinue use if occurs<\/li><li>report suspected adverse reactions to the US Food and Drug Administration at 1-800-FDA-1088 or www.fda.gov\/medwatch<\/li><\/ul>"},{"id":"jtuus3b11","title":"Pregnancy Category","mono":"<ul><li>B (FDA)<\/li><li>B3 (AUS)<\/li><\/ul>"},{"id":"jtuus3b12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"jtuus5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Dermatologic:<\/b>Application site reaction, (shampoo), Erythema, Periungual, Pruritus, Sensation of burning of skin<br\/>"},"6":{"id":"jtuus6","title":"Drug Name Info","sub":{"0":{"id":"jtuus6b17","title":"US Trade Names","mono":"<ul><li>Loprox<\/li><li>Loprox TS<\/li><li>Penlac<\/li><li>CNL8<\/li><li>Ciclodan<\/li><\/ul>"},"2":{"id":"jtuus6b19","title":"Class","mono":"Antifungal<br\/>"},"3":{"id":"jtuus6b20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"jtuus6b21","title":"Generic Availability","mono":"Yes<br\/>"}}},"7":{"id":"jtuus7","title":"Mechanism Of Action","mono":"Topical: Exact mechanism unknown; fungicidal  in vitro  against Trichophyton rubrum, T. mentagrophytes, Epidermophyton floccosum (Acrothesium floccosum), Microsporum canis, and Candida albicans (Monilia albicans); may inhibit transport of certain essential substrates into fungal cells; may also interfere with the synthesis of proteins, RNA, and DNA in growing fungal cells; alterations in cell permeability, osmotic fragility, and endogenous respiration are affected only at high concentrations of ciclopirox.  <br\/>"},"8":{"id":"jtuus8","title":"Pharmacokinetics","sub":{"0":{"id":"jtuus8b23","title":"Absorption","mono":"Topical: Bioavailability: 1% Solution- 1.3%; 8% Solution- &lt;5%; Cream and Lotion- 0.8 to 1.6%<br\/>"},"3":{"id":"jtuus8b26","title":"Excretion","mono":"Topical: Fecal: neglible; Renal <br\/>"},"4":{"id":"jtuus8b27","title":"Elimination Half Life","mono":"Topical: 1.7 h <br\/>"}}},"9":{"id":"jtuus9","title":"Administration","mono":"<b>Topical<\/b><br\/><ul><li>(gel) gently massage into affected area and surrounding skin immediately after cleaning or washing the area<\/li><li>(shampoo) wet hair, apply 5-10 mL to scalp; lather and leave on hair and scalp for 3 minutes (a timer may be used)<\/li><li>(shampoo) treatment should be repeated twice a week for 4 weeks (minimum 3 days between applications)<\/li><li>(nail solution) apply once daily to affected nails (preferably at bedtime) with supplied applicator brush; wait 30 seconds for application to dry; wait 8 hours after application before bathing or showering<\/li><li>(nail solution) remove previous coats with alcohol, file loose nail materials, and trim nails every 7 days<\/li><\/ul>"},"10":{"id":"jtuus10","title":"Monitoring","mono":"<ul><li>resolution of symptoms (erythema, scaling, pruritus)<\/li><li>increased irritation (erythema, burning, blistering, swelling, oozing or itching) at application site<\/li><li>no improvement in or worsening of symptoms<\/li><\/ul>"},"11":{"id":"jtuus11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/><ul><li>Topical Cream: 0.77 %<\/li><li>Topical Gel\/Jelly: 0.77 %<\/li><li>Topical Shampoo: 1 %<\/li><li>Topical Solution: 8 %<\/li><li>Topical Suspension: 0.77 %<\/li><\/ul><\/li><li><b>Ciclodan<\/b><br\/>Topical Solution: 8 %<br\/><\/li><li><b>CNL8<\/b><br\/>Topical Solution: 8 %<br\/><\/li><li><b>Loprox<\/b><br\/><ul><li>Topical Cream: 0.77 %<\/li><li>Topical Gel\/Jelly: 0.77 %<\/li><li>Topical Shampoo: 1 %<\/li><\/ul><\/li><li><b>Penlac Nail Lacquer<\/b><br\/>Topical Solution: 8 %<br\/><\/li><li><b>Penlac<\/b><br\/>Topical Solution: 8 %<br\/><\/li><\/ul>"},"13":{"id":"jtuus13","title":"Clinical Teaching","mono":"<ul><li>This drug may cause erythema, pruritus, or a burning sensation when applied.<\/li><li>Instruct patient to report signs\/symptoms of increased irritation (erythema, burning, blistering, swelling, oozing, itching) at application site.<\/li><li>Tell patients that drug is not for ophthalmic, oral, or intravaginal use. Avoid contact with mucous membranes.<\/li><li>Advise patient to avoid use of occlusive dressings.<\/li><li>Advise patients treating fingernails or toenails not to use nail polish during treatment.<\/li><\/ul>"}}}